{
    "xml": "<topic id=\"PHP93596\" outputclass=\"drug\" rev=\"1.10\" type=\"drug\" namespace=\"/drugs/bedaquiline\" basename=\"bedaquiline\" title=\"BEDAQUILINE\">\n<title>BEDAQUILINE</title>\n<body>\r\n<p outputclass=\"interactionsLinks\"> List of individual interactants: <xref format=\"dita\" href=\"#bnf_int_1310\" namespace=\"/interactions/list-of-drug-interactions/antibacterials/bedaquiline\">Bedaquiline</xref>\n</p>\n<data name=\"vtmid\">24564711000001103</data>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_173703585\" title=\"Diarylquinolines\">Diarylquinolines</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">  </data>\n</data>\r\n</body>\n<topic id=\"PHP93912\" outputclass=\"indicationsAndDose\" rev=\"1.18\" parent=\"/drugs/bedaquiline\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Multiple-drug resistant pulmonary tuberculosis, in combination with other drugs</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Initially 400&#8239;mg once daily for 2 weeks, then 200&#8239;mg 3 times a week for 22 weeks, intervals of at least 48 hours between each dose, continue appropriate combination therapy after bedaquiline.</p>\n</li>\n</ul>\n</section>\n</body>\n</topic>\n<topic id=\"PHP93907\" outputclass=\"contraindications\" rev=\"1.11\" parent=\"/drugs/bedaquiline\">\n<title>Contra-indications</title>\n<body>\n<section outputclass=\"contraindications\">\n<p>\n<ph outputclass=\"contraindication\">QTc interval more than 500 milliseconds (derived using Fridericia's formula)</ph>; <ph outputclass=\"contraindication\">ventricular arrhythmia</ph>\n</p>\n</section>\n</body>\n</topic>\n<topic id=\"PHP93905\" outputclass=\"cautions\" rev=\"1.21\" parent=\"/drugs/bedaquiline\">\n<title>Cautions</title>\n<body>\n<section outputclass=\"cautions\">\n<p>\n<ph outputclass=\"caution\">Hypothyroidism</ph>; <ph outputclass=\"caution\">QTc interval (derived using Fridericia's formula) 450&#8211;500 milliseconds&#8212;discontinue if QTc interval more than 500 milliseconds</ph>; <ph outputclass=\"caution\">risk factors for QT interval prolongation (e.g. electrolyte disturbances, heart failure with reduced left ventricular ejection fraction, history of symptomatic arrhythmias (avoid if ventricular arrhythmia present), bradycardia, congenital long QT syndrome)</ph>\n</p>\n</section>\n</body>\n</topic>\n<topic id=\"PHP93913\" outputclass=\"interactions\" rev=\"1.16\" parent=\"/drugs/bedaquiline\">\n<title>Interactions</title>\n<body>\n<section outputclass=\"general\">\n<sectiondiv>\n<p>Appendix 1 (bedaquiline).</p>\n<p>Caution with concomitant use of hepatotoxic drugs.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP93918\" outputclass=\"sideEffects\" rev=\"1.18\" parent=\"/drugs/bedaquiline\">\n<title>Side-effects</title>\n<body>\n<section outputclass=\"generalSideEffects\">\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"notKnown\">\n<p outputclass=\"title\">Frequency not known</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Arthralgia</ph>; <ph outputclass=\"sideEffect\">diarrhoea</ph>; <ph outputclass=\"sideEffect\">dizziness</ph>; <ph outputclass=\"sideEffect\">headache</ph>; <ph outputclass=\"sideEffect\">myalgia</ph>; <ph outputclass=\"sideEffect\">nausea</ph>; <ph outputclass=\"sideEffect\">QT interval prolongation</ph>; <ph outputclass=\"sideEffect\">vomiting</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n<section outputclass=\"sideEffectsAdvice\">\n<title>Side-effects, further information</title>\n<sectiondiv>\n<p outputclass=\"title\">Syncope</p>\n<p>If syncope occurs, obtain ECG.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP93914\" outputclass=\"pregnancy\" parent=\"/drugs/bedaquiline\">\n<title>Pregnancy</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Manufacturer advises avoid unless potential benefit outweighs risk.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP93904\" outputclass=\"breastFeeding\" parent=\"/drugs/bedaquiline\">\n<title>Breast feeding</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Manufacturer advises avoid&#8212;present in milk in <i>animal</i> studies.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP93911\" outputclass=\"hepaticImpairment\" parent=\"/drugs/bedaquiline\">\n<title>Hepatic impairment</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Manufacturer advises caution in moderate impairment; avoid in severe impairment&#8212;no information available. Avoid concomitant use of hepatotoxic drugs unless essential.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP93916\" outputclass=\"renalImpairment\" parent=\"/drugs/bedaquiline\">\n<title>Renal impairment</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Manufacturer advises caution if eGFR less than 30&#8239;mL/minute/1.73&#8239;m<sup>2</sup>.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP93922\" outputclass=\"monitoringRequirements\" parent=\"/drugs/bedaquiline\">\n<title>Monitoring requirements</title>\n<body>\n<section outputclass=\"monitoringOfPatientParameters\">\n<sectiondiv>\n<p>Determine serum potassium, calcium, and magnesium before starting treatment (correct if abnormal)&#8212;remeasure if QT prolongation occurs during treatment.</p>\n<p>Obtain ECG before starting treatment, and then at least monthly during treatment or more frequently if concomitant use with other drugs known to prolong the QT interval.</p>\n<p>Monitor liver function before starting treatment and then at least monthly during treatment&#8212;discontinue treatment if severe abnormalities in liver function tests.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP93915\" outputclass=\"patientAndCarerAdvice\" rev=\"1.13\" parent=\"/drugs/bedaquiline\">\n<title>Patient and carer advice</title>\n<body>\n<section outputclass=\"adviceAroundMissedDoses\">\n<title>Missed doses</title>\n<sectiondiv>\n<p>If a dose is missed during the first two weeks of treatment, the missed dose should not be taken and the next dose should be taken at the usual time; if a dose is missed during weeks 3&#8211;24 of treatment, the missed dose should be taken as soon as possible and then the usual regimen resumed.</p>\n</sectiondiv>\n</section>\n<section outputclass=\"adviceAroundDrivingAndOtherTasks\">\n<title>Driving and skilled tasks</title>\n<sectiondiv>\n<p>Dizziness may affect performance of skilled tasks (e.g. driving)</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP93596-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/bedaquiline\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP101374\" title=\"Tablet\" namespace=\"/drugs/bedaquiline/tablet\">Tablet</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"1\" rel=\"backlink\">Drug classifications</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78330\" namespace=\"/treatment-summaries/tuberculosis\" title=\"Tuberculosis\" count=\"2\" rel=\"backlink\">Tuberculosis</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_1310\" namespace=\"/interactions/list-of-drug-interactions/antibacterials/bedaquiline\" title=\"Bedaquiline\" count=\"1\" rel=\"link\">Bedaquiline</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP101374\" namespace=\"/drugs/bedaquiline/tablet\" title=\"Tablet\" count=\"1\" rel=\"link\">Tablet</xref>\n</links>\n</topic>",
    "id": "PHP93596",
    "outputclass": "drug",
    "rev": "1.10",
    "type": "drug",
    "namespace": "/drugs/bedaquiline",
    "basename": "bedaquiline",
    "title": "BEDAQUILINE",
    "interactants": [
        {
            "id": "bnf_int_1310",
            "label": "Bedaquiline"
        }
    ],
    "vtmid": "24564711000001103",
    "drugClassification": [
        "Diarylquinolines"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Multiple-drug resistant pulmonary tuberculosis, in combination with other drugs",
                        "html": "Multiple-drug resistant pulmonary tuberculosis, in combination with other drugs"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "Initially 400 mg once daily for 2 weeks, then 200 mg 3 times a week for 22 weeks, intervals of at least 48 hours between each dose, continue appropriate combination therapy after bedaquiline.",
                        "html": "<p>Initially 400&#8239;mg once daily for 2 weeks, then 200&#8239;mg 3 times a week for 22 weeks, intervals of at least 48 hours between each dose, continue appropriate combination therapy after bedaquiline.</p>"
                    }
                ]
            }
        ]
    },
    "contraindications": {
        "contraindications": [
            {
                "type": "contraindications",
                "textContent": "QTc interval more than 500 milliseconds (derived using Fridericia's formula)",
                "html": "QTc interval more than 500 milliseconds (derived using Fridericia's formula)"
            },
            {
                "type": "contraindications",
                "textContent": "ventricular arrhythmia",
                "html": "ventricular arrhythmia"
            }
        ]
    },
    "cautions": {
        "cautions": [
            {
                "type": "cautions",
                "textContent": "Hypothyroidism",
                "html": "Hypothyroidism"
            },
            {
                "type": "cautions",
                "textContent": "QTc interval (derived using Fridericia's formula) 450&#8211;500 milliseconds&#8212;discontinue if QTc interval more than 500 milliseconds",
                "html": "QTc interval (derived using Fridericia's formula) 450&#8211;500 milliseconds&#8212;discontinue if QTc interval more than 500 milliseconds"
            },
            {
                "type": "cautions",
                "textContent": "risk factors for QT interval prolongation (e.g. electrolyte disturbances, heart failure with reduced left ventricular ejection fraction, history of symptomatic arrhythmias (avoid if ventricular arrhythmia present), bradycardia, congenital long QT syndrome)",
                "html": "risk factors for QT interval prolongation (e.g. electrolyte disturbances, heart failure with reduced left ventricular ejection fraction, history of symptomatic arrhythmias (avoid if ventricular arrhythmia present), bradycardia, congenital long QT syndrome)"
            }
        ]
    },
    "interactions": {
        "general": [
            {
                "type": "general",
                "textContent": "Appendix 1 (bedaquiline).\n\nCaution with concomitant use of hepatotoxic drugs.",
                "html": "<p>Appendix 1 (bedaquiline).</p><p>Caution with concomitant use of hepatotoxic drugs.</p>"
            }
        ]
    },
    "sideEffects": {
        "general": {
            "frequencies": {
                "notKnown": [
                    {
                        "type": "notKnown",
                        "textContent": "Arthralgia",
                        "html": "Arthralgia",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "diarrhoea",
                        "html": "diarrhoea",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "dizziness",
                        "html": "dizziness",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "headache",
                        "html": "headache",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "myalgia",
                        "html": "myalgia",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "nausea",
                        "html": "nausea",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "QT interval prolongation",
                        "html": "QT interval prolongation",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "vomiting",
                        "html": "vomiting",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    }
                ]
            }
        },
        "advice": [
            {
                "type": "advice",
                "title": "Syncope",
                "textContent": "If syncope occurs, obtain ECG.",
                "html": "<p>If syncope occurs, obtain ECG.</p>"
            }
        ]
    },
    "pregnancy": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Manufacturer advises avoid unless potential benefit outweighs risk.",
                "html": "<p>Manufacturer advises avoid unless potential benefit outweighs risk.</p>"
            }
        ]
    },
    "breastFeeding": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Manufacturer advises avoid&#8212;present in milk in animal studies.",
                "html": "<p>Manufacturer advises avoid&#8212;present in milk in <i>animal</i> studies.</p>"
            }
        ]
    },
    "hepaticImpairment": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Manufacturer advises caution in moderate impairment; avoid in severe impairment&#8212;no information available. Avoid concomitant use of hepatotoxic drugs unless essential.",
                "html": "<p>Manufacturer advises caution in moderate impairment; avoid in severe impairment&#8212;no information available. Avoid concomitant use of hepatotoxic drugs unless essential.</p>"
            }
        ]
    },
    "renalImpairment": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Manufacturer advises caution if eGFR less than 30 mL/minute/1.73 m2.",
                "html": "<p>Manufacturer advises caution if eGFR less than 30&#8239;mL/minute/1.73&#8239;m<sup>2</sup>.</p>"
            }
        ]
    },
    "monitoringRequirements": {
        "patientParameters": [
            {
                "type": "patientParameters",
                "textContent": "Determine serum potassium, calcium, and magnesium before starting treatment (correct if abnormal)&#8212;remeasure if QT prolongation occurs during treatment.\n\nObtain ECG before starting treatment, and then at least monthly during treatment or more frequently if concomitant use with other drugs known to prolong the QT interval.\n\nMonitor liver function before starting treatment and then at least monthly during treatment&#8212;discontinue treatment if severe abnormalities in liver function tests.",
                "html": "<p>Determine serum potassium, calcium, and magnesium before starting treatment (correct if abnormal)&#8212;remeasure if QT prolongation occurs during treatment.</p><p>Obtain ECG before starting treatment, and then at least monthly during treatment or more frequently if concomitant use with other drugs known to prolong the QT interval.</p><p>Monitor liver function before starting treatment and then at least monthly during treatment&#8212;discontinue treatment if severe abnormalities in liver function tests.</p>"
            }
        ]
    },
    "patientAndCarerAdvice": {
        "adviceAroundMissedDoses": [
            {
                "type": "adviceAroundMissedDoses",
                "textContent": "If a dose is missed during the first two weeks of treatment, the missed dose should not be taken and the next dose should be taken at the usual time; if a dose is missed during weeks 3&#8211;24 of treatment, the missed dose should be taken as soon as possible and then the usual regimen resumed.",
                "html": "<p>If a dose is missed during the first two weeks of treatment, the missed dose should not be taken and the next dose should be taken at the usual time; if a dose is missed during weeks 3&#8211;24 of treatment, the missed dose should be taken as soon as possible and then the usual regimen resumed.</p>"
            }
        ],
        "adviceAroundDrivingAndOtherTasks": [
            {
                "type": "adviceAroundDrivingAndOtherTasks",
                "textContent": "Dizziness may affect performance of skilled tasks (e.g. driving)",
                "html": "<p>Dizziness may affect performance of skilled tasks (e.g. driving)</p>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ]
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP101374",
                "label": "Tablet",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ],
        "treatmentSummary": [
            {
                "id": "PHP78330",
                "label": "Tuberculosis",
                "type": "treatmentSummary"
            }
        ]
    },
    "links": {
        "interaction": [
            {
                "id": "bnf_int_1310",
                "label": "Bedaquiline",
                "type": "interaction"
            }
        ],
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP101374",
                "label": "Tablet",
                "type": "medicinalForm"
            }
        ]
    }
}